Key clinical point: Women with HIV on dolutegravir-based antiretroviral therapy protocols had higher weights through 18 months of the postpartum period than women on efavirenz-based therapy, but similar postpartum weights to women who did not have HIV.
Major finding: Women on a dolutegravir-based regiment weighed an average of 5 kg more post partum than women on an efavirenz-based regiment. (P less than .01).
Study details: The study was a secondary analysis of the Botswanan Tshilo Dikotla study that included 406 women.
Disclosures: The study was supported by the National Institutes of Health. Dr. Jao reported no relevant conflicts of interest.
Jao J et al. CROI 2020, Poster 00772.